10.09
price down icon2.79%   -0.29
after-market After Hours: 10.16 0.07 +0.69%
loading
Roivant Sciences Ltd stock is traded at $10.09, with a volume of 7.33M. It is down -2.79% in the last 24 hours and down -6.05% over the past month.
See More
Previous Close:
$10.38
Open:
$10.18
24h Volume:
7.33M
Relative Volume:
1.48
Market Cap:
$7.73B
Revenue:
$125.68M
Net Income/Loss:
$4.81B
P/E Ratio:
1.7858
EPS:
5.65
Net Cash Flow:
$-781.21M
1W Performance:
-6.83%
1M Performance:
-6.05%
6M Performance:
-12.56%
1Y Performance:
-4.27%
1-Day Range:
Value
$9.92
$10.22
1-Week Range:
Value
$9.92
$10.90
52-Week Range:
Value
$9.92
$13.05

Roivant Sciences Ltd Stock (ROIV) Company Profile

Name
Name
Roivant Sciences Ltd
Name
Phone
441-295-5950
Name
Address
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2025-02-10
Name
Latest SEC Filings
Name
ROIV's Discussions on Twitter

Compare ROIV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ROIV
Roivant Sciences Ltd
10.09 7.73B 125.68M 4.81B -781.21M 5.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-15-24 Initiated Wolfe Research Outperform
Jan-05-24 Initiated Piper Sandler Overweight
Dec-12-23 Initiated Deutsche Bank Buy
Oct-17-23 Initiated Guggenheim Buy
Jun-08-23 Initiated BofA Securities Neutral
Oct-27-22 Initiated JP Morgan Overweight
May-23-22 Initiated SVB Leerink Outperform
Apr-29-22 Initiated Cantor Fitzgerald Overweight
Dec-15-21 Initiated Goldman Buy
Nov-08-21 Initiated H.C. Wainwright Buy
Oct-28-21 Initiated Citigroup Buy
Oct-26-21 Initiated Cowen Outperform
Oct-26-21 Initiated Jefferies Buy
Oct-26-21 Initiated Truist Buy
View All

Roivant Sciences Ltd Stock (ROIV) Latest News

pulisher
10:33 AM

ROIV stock touches 52-week low at $9.96 amid market fluctuations - Investing.com

10:33 AM
pulisher
Mar 29, 2025

Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Loomis Sayles & Co. L P Has $43.43 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 315,522 Shares of Stock - MarketBeat

Mar 28, 2025
pulisher
Mar 25, 2025

Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Insider Monkey

Mar 25, 2025
pulisher
Mar 24, 2025

Roivant Sciences president Eric Venker sells shares worth $8.19 million - Investing.com

Mar 24, 2025
pulisher
Mar 23, 2025

Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

(ROIV) Trading Advice - news.stocktradersdaily.com

Mar 23, 2025
pulisher
Mar 20, 2025

Roivant Sciences finalizes consulting agreement with former officer - Investing.com India

Mar 20, 2025
pulisher
Mar 19, 2025

Roivant Phase III Batoclimab Trial Is Positive, But No Filing Planned - insights.citeline.com

Mar 19, 2025
pulisher
Mar 19, 2025

Roivant Sciences Says Phase 3 MG Study Meets Primary Endpoint -March 19, 2025 at 08:24 am EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Roivant Sciences Announces Positive Results for Batoclimab Studies - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Immunovant Ditches Seeking FDA Approval For Batoclimab For Two Autoimmune Disorders Despite Positive Phase 3 Data - Yahoo Finance

Mar 19, 2025
pulisher
Mar 12, 2025

(ROIV) Trading Signals - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Roivant at Leerink’s Conference: Strategic Insights and Developments By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 07, 2025

Does Roivant (ROIV) Offer an Attractive Risk Reward Opportunity? - Insider Monkey

Mar 07, 2025
pulisher
Mar 04, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

Roivant Sciences Ltd. (ROIV): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Mar 02, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by New York State Common Retirement Fund - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Trend Tracker for (ROIV) - Stock Traders Daily

Mar 01, 2025
pulisher
Feb 28, 2025

Principal Financial Group Inc. Lowers Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Handelsbanken Fonder AB Trims Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Net worth of Vivek Ramaswamy: Roviant Sciences founder who is running for Ohio governor - Times of India

Feb 27, 2025
pulisher
Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62‐103: Roivant announces Resignation and Replacement of Arbutus Board - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62?103: Roivant announces Resignation and Replacement of Arbutus Board - Lelezard

Feb 25, 2025
pulisher
Feb 24, 2025

Roivant Sciences president Eric Venker sells $1.07 million in shares - Investing.com India

Feb 24, 2025
pulisher
Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Roivant Sciences Appoints New Chief Accounting Officer - TipRanks

Feb 21, 2025
pulisher
Feb 20, 2025

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. - The Motley Fool

Feb 20, 2025
pulisher
Feb 19, 2025

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) CAO Sells 227,500 Shares of Stock - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Long Term Trading Analysis for (ROIV) - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 19, 2025

Roivant Sciences’ chief accounting officer sells $2.37 million in shares - Investing.com India

Feb 19, 2025
pulisher
Feb 18, 2025

Roivant Sciences' chief accounting officer sells $2.37 million in shares By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences’ chief accounting officer sells $2.37 million in shares By Investing.com - Investing.com Nigeria

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences' chief accounting officer sells $2.37 million in shares - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 218,041 Shares - MarketBeat

Feb 18, 2025
pulisher
Feb 16, 2025

Roivant Sciences president Eric Venker sells over $4.56 million in stock - MSN

Feb 16, 2025
pulisher
Feb 15, 2025

Roivant Sciences president Eric Venker sells over $4.56 million in stock By Investing.com - Investing.com South Africa

Feb 15, 2025

Roivant Sciences Ltd Stock (ROIV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Cap:     |  Volume (24h):